The University of Chicago Header Logo

Connection

Olatoyosi Odenike to Propensity Score

Back to Details
This is a "connection" page, showing publications Olatoyosi Odenike has written about Propensity Score.
Olatoyosi Odenike
Connection Strength
0.055
Propensity Score
  1. Oral decitabine cedazuridine with and without venetoclax in higher-risk myelodysplastic syndromes or chronic myelomonocytic leukemia: a propensity score-matched study. Blood Cancer J. 2025 Mar 31; 15(1):50.
    View in: PubMed
    Score: 0.055
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.